new version V2017

     

pdf
TrialStudied treatmentControl treatmentpatientsROBResultNCT

diabetes type 2

ALECARDIOaleglitazarplacebo - NCT01042769
ALEPREVENTaleglitazarplacebo - EUDRACT201200067116
ALECARDIO, 2014aleglitazarplacebo Exploratory NegativeNCT01042769
BC20265 ongoing aleglitazaractos - NCT00461058
BC22140 ongoing aleglitazarplacebo - NCT01042769